AR SB582

First offense convictions for rape, sexual assault in the first degree, or sexual assault in the second degree with victims age 12 or younger may result in court-ordered medroxyprogesterone acetate treatment as an enhanced sentence, subject to medical evaluation.

Second or subsequent convictions for the same offenses with victims age 12 or younger shall result in mandatory court-ordered medroxyprogesterone acetate treatment monitored by the Department of Corrections.

Court must appoint a medical expert to determine if the defendant is an appropriate candidate for treatment within 60 days of sentencing, and the court specifies treatment duration for a specific term of years or up to the defendant's lifetime.

Department of Corrections administers and monitors treatment, with incarcerated offenders beginning treatment no later than one week before release from prison.

Defendants may elect physical castration as a written alternative to medroxyprogesterone acetate treatment if they provide voluntary informed consent to the court.